Supernus Pharmaceuticals, Inc. - Common Stock (NQ:SUPN)
Price and Volume
Detailed Quote| Volume | 5 |
| Open | 41.92 |
| Bid (Size) | 11.20 (200) |
| Ask (Size) | 37.20 (100) |
| Prev. Close | 41.92 |
| Today's Range | 41.92 - 41.92 |
| 52wk Range | 37.54 - 59.68 |
| Shares Outstanding | 53,145,884 |
| Dividend Yield | N/A |
Top News
More News
Performance
52-Week Range
29.8% below 52-week high
41.92
37.5452W Low
59.6852W High
1 Week
5.4% below 1-week high
39.671W Low
44.311W High
Supernus Pharmaceuticals, Inc. - Common Stock (SUPN) traded between $37.54 and $59.68 over the past 52 weeks and last traded at $41.92, 29.8% below its 52-week high. Over the past week it ranged between $39.67 and $44.31.
Past 12 Months
1W
+$0.96
1M
-$0.84
3M
-$4.08
6M
-$6.71
YTD
-$7.55
1Y
-$13.78
SUPN was -24.7% over the past year, -13.8% over six months, -15.3% year to date, +2.3% in the last week.
12 Months vs Market
SUPN
-24.7%
DIA
+9.7%
SPY
+10.1%
QQQ
+7.8%
IWM
+13.7%
Over the past 12 months SUPN returned -24.7% versus DIA (Dow) +9.7%, SPY (S&P 500) +10.1%, QQQ (Nasdaq 100) +7.8% and IWM (Russell 2000) +13.7%.
Volume & Liquidity
0.00× 3-mo avg
Today 5
3-mo avg 877.6K
1W
1.0M
1M
1.0M
3M
877.6K
6M
822.2K
YTD
768.1K
1Y
780.2K
SUPN most recently traded 5 shares against a 3-month average daily volume of 877.6K.
More News
Read More
Supernus (SUPN) Q3 2026 Earnings Call Transcript ↗
October 30, 2026
Supernus Pharmaceuticals Q3 Earnings Call Highlights ↗
October 29, 2026
Supernus Announces Third Quarter 2026 Financial Results
October 29, 2026
Supernus Pharmaceuticals earnings: what to look for from SUPN
October 27, 2026
1 Russell 2000 Stock with Exciting Potential and 2 We Ignore
October 14, 2026
1 Healthcare Stock Worth Your Attention and 2 We Turn Down
October 09, 2026
1 Unprofitable Stock with Impressive Fundamentals and 2 We Avoid
September 30, 2026
2 Growth Stocks to Add to Your Roster and 1 We Question
September 28, 2026
3 Reasons SUPN is Risky and 1 Stock to Buy Instead
September 21, 2026
3 Cash-Heavy Stocks Walking a Fine Line
September 16, 2026
Supernus Pharmaceuticals to Participate in September Investor Conferences
September 02, 2026
3 Out-of-Favor Stocks We’re Skeptical Of
September 02, 2026
3 Small-Cap Stocks with Open Questions
August 25, 2026
Frequently Asked Questions
Is Supernus Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Supernus Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Supernus Pharmaceuticals, Inc. - Common Stock trade on?
Supernus Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Supernus Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Supernus Pharmaceuticals, Inc. - Common Stock is SUPN on the Nasdaq Stock Market
What is the current price of Supernus Pharmaceuticals, Inc. - Common Stock?
The current price of Supernus Pharmaceuticals, Inc. - Common Stock is 41.92
When was Supernus Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Supernus Pharmaceuticals, Inc. - Common Stock was at 10/30/26 04:00 PM ET
What is the market capitalization of Supernus Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Supernus Pharmaceuticals, Inc. - Common Stock is 2.23B
How many shares of Supernus Pharmaceuticals, Inc. - Common Stock are outstanding?
Supernus Pharmaceuticals, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.